BioScrip Company Profile (NASDAQ:BIOS)

About BioScrip

BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Home Health Care
• Sub-Industry: Health Care Services
• Exchange: NASDAQ
• Symbol: BIOS
• CUSIP: 09069N10

Key Metrics:

• Previous Close: $2.92
• 50 Day Moving Average: $2.736
• 200 Day Moving Average: $2.570
• 52-Week Range: $1.19 - $3.09
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -36.13
• P/E Growth: -0.840
• Market Cap: $331.96M
• Outstanding Shares: 113,880,000
• Beta: 0.68

Profitability:

• Net Margins: -5.63%
• Return on Equity: -609.04%
• Return on Assets: -6.27%

Debt:

• Debt-to-Equity Ratio: -21.59%
• Current Ratio: 1.96%
• Quick Ratio: 1.64%

Additional Links:

• Visit BioScrip's Official Website
• View BIOS on Google Finance
• View BIOS on Yahoo Finance
• View BIOS's Company Profile on Reuters
• Search for BioScrip Inc. on Google

Companies Related to BioScrip:

• Novadaq Technologies (NASDAQ:NVDQ)
• Aimmune Therapeutics (NASDAQ:AIMT)
• CoLucid Pharmaceuticals (NASDAQ:CLCD)
• NantKwest (NASDAQ:NK)
• NeoGenomics (NASDAQ:NEO)
• Atara Biotherapeutics (NASDAQ:ATRA)
• AngioDynamics (NASDAQ:ANGO)
• Agenus (NASDAQ:AGEN)
• Ardelyx (NASDAQ:ARDX)
• CryoLife (NYSE:CRY)

Earnings

Earnings History for BioScrip (NASDAQ:BIOS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/2/2016
8/8/2016	Q216	($0.09)	($0.14)	$229.58 million	$232.50 million	View	Listen
5/5/2016	Q1	($0.12)	($0.17)	$232.38 million	$238.50 million	View	Listen
3/2/2016	Q4	($0.08)	($0.13)	$238.30 million	$243.75 million	View	Listen
11/4/2015	Q315	($0.10)	($0.38)	$229.89 million	$247.20 million	View	Listen
8/10/2015	Q215	($0.11)	($3.60)	$269.38 million	$262.40 million	View	Listen
5/7/2015	Q115	($0.04)	($0.17)	$259.60 million	$261.70 million	View	Listen
3/2/2015	Q414	$0.01	($0.69)	$259.62 million	$253.70 million	View	Listen
11/5/2014	Q314	$0.02	($0.42)	$240.08 million	$244.00 million	View	Listen
8/6/2014	Q214	($0.02)	($0.01)	$233.70 million	$247.10 million	View	Listen
5/8/2014	Q114	($0.03)	($0.13)	$222.65 million	$239.60 million	View	Listen
2/26/2014	Q413	$0.02	$0.02	$237.58 million	$243.50 million	View	Listen
8/7/2013	Q2 2013	$0.04	$0.13	$206.47 million	$190.73 million	View	Listen
5/8/2013	Q1 2013	$0.02	$0.04	$189.36 million	$199.07 million	View	Listen
3/11/2013	Q4 2012	$0.01	$0.04	$173.87 million	$180.70 million	View	Listen
11/7/2012	Q312	($0.01)	($0.01)	$159.86 million	$170.36 million	View	N/A
8/8/2012		($0.01)	($0.07)			View	N/A
5/9/2012		($0.01)	($0.05)			View	N/A
3/9/2012		$0.09	$0.12			View	N/A
11/8/2011		$0.09	$0.10			View	N/A
8/8/2011		$0.08	$0.10			View	N/A
5/3/2011		($0.01)	$0.05			View	N/A
3/11/2011		$0.04	($1.25)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioScrip (NASDAQ:BIOS)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q3 2016	1	($0.07)	($0.07)	($0.07)
Q4 2016	3	($0.04)	$0.01	($0.01)
Q1 2017	2	($0.08)	($0.06)	($0.07)
Q2 2017	2	($0.06)	($0.03)	($0.05)
Q3 2017	2	($0.04)	($0.03)	($0.04)
Q4 2017	2	($0.01)	$0.00	($0.01)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioScrip (NASDAQ:BIOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioScrip (NASDAQ:BIOS)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
6/22/2016	Coliseum Capital Management, L	Director	Buy	4,200,000	$2.00	$8,400,000.00
6/17/2016	David W Golding	Director	Buy	12,500	$2.48	$31,000.00
8/24/2015	Coliseum Capital Management, L	Director	Buy	789,503	$1.88	$1,484,265.64
8/21/2015	Coliseum Capital Management, L	Director	Buy	632,907	$1.81	$1,145,561.67
8/18/2015	David W Golding	Director	Buy	20,000	$1.54	$30,800.00
3/16/2015	Richard M Smith	CEO	Buy	5,000	$4.27	$21,350.00
3/12/2015	Yon Jorden	Director	Buy	5,000	$3.47	$17,350.00
6/16/2014	Myron Z Holubiak	Director	Sell	5,000	$7.94	$39,700.00
5/14/2014	Yon Jorden	Director	Buy	5,000	$7.21	$36,050.00
8/30/2013	Daniel Colucci	VP	Sell	18,500	$12.40	$229,400.00
8/28/2013	David Hubers	Director	Sell	11,200	$12.23	$136,976.00
8/28/2013	Patricia Bogusz	VP	Sell	39,687	$11.94	$473,862.78
8/19/2013	Kohlberg Management V, Llc	Insider	Sell	6,895,873	$13.00	$89,646,349.00
7/19/2013	Myron Z Holubiak	Director	Sell	31,200	$16.34	$509,808.00
11/13/2012	Stuart A Samuels	Director	Sell	11,200	$9.66	$108,192.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioScrip (NASDAQ:BIOS)

Date	Headline
	BioScrip, Inc. (NASDAQ:BIOS) Updated Broker Price Targets - The De Soto Edge (NASDAQ:BIOS) desotoedge.com - September 29 at 8:32 AM
	Interested Penny Stock Investors Keen on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 28 at 3:38 PM
	Penny Stock Investors are Growing Curious About BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 27 at 3:51 PM
	Under the Microscope: Zeroing in on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 26 at 3:58 PM
	BioScrip, Inc. (NASDAQ:BIOS) Mean Price Target At $3.916 - RealistInvestor.com (NASDAQ:BIOS) www.realistinvestor.com - September 26 at 3:58 PM
	Keen Investors Find News on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 24 at 8:05 AM
	Penny Stock Investors Keen on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 21 at 3:17 PM
	Quarterly Financial Update for BioScrip, Inc. (NASDAQ:BIOS) - Newburgh Press (NASDAQ:BIOS) newburghpress.com - September 21 at 8:23 AM
	Penny Stock Investors Take an Interest in BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 21 at 8:23 AM
	Consensus Take: BioScrip, Inc. (NASDAQ:BIOS) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:BIOS) friscofastball.com - September 21 at 8:23 AM
	Research Reports Coverage on Healthcare Stocks -- Aetna, Anthem, Humana, and BioScrip - PR Newswire (press release) (NASDAQ:BIOS) www.prnewswire.com - September 21 at 8:23 AM
	BioScrip, Inc. (NASDAQ:BIOS) Mean Price Target At $3.916 - Investor Newswire (NASDAQ:BIOS) www.investornewswire.com - September 17 at 3:47 PM
	Keen Investors Seek Information on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 17 at 8:38 AM
	BioScrip Buys Home Solutions, Strengthens Infusion Business - Nasdaq (NASDAQ:BIOS) www.nasdaq.com - September 15 at 8:46 PM
	Stock Update, a Closer Look at BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 15 at 3:38 PM
	Business Briefs: BioScrip Closes Acqusition With Home Solutions (NASDAQ:BIOS) homehealthcarenews.com - September 14 at 9:04 PM
	BioScrip (BIOS) Announces Completion of HS Infusion Holdings Acquisition (NASDAQ:BIOS) www.streetinsider.com - September 14 at 9:04 PM
	Keen Investors Narrowing Their Focus on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 14 at 3:52 PM
	BioScrip Buys Home Solutions, Strengthens Infusion Business (NASDAQ:BIOS) finance.yahoo.com - September 14 at 3:52 PM
	Penny Stock Investors Highly Curious in Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 13 at 5:03 PM
	BioScrip, Inc. (NASDAQ:BIOS) Is Expected To Post EPS Of $-0.02 - RealistInvestor.com (NASDAQ:BIOS) www.realistinvestor.com - September 13 at 5:03 PM
	Business Briefs: BioScrip Closes Acqusition With Home Solutions - Home Health Care News (NASDAQ:BIOS) homehealthcarenews.com - September 13 at 8:42 AM
	BIOSCRIP, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Directors or Princip (NASDAQ:BIOS) biz.yahoo.com - September 13 at 8:42 AM
	BioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : September 13, 2016 (NASDAQ:BIOS) www.capitalcube.com - September 13 at 8:42 AM
	Getting a Closer Look at Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 12 at 3:45 PM
	BioScrip, Inc. (NASDAQ:BIOS) Mean Price Target Is $3.916 - RealistInvestor.com (NASDAQ:BIOS) www.realistinvestor.com - September 12 at 3:45 PM
	BioScrip (BIOS) Announces Completion of HS Infusion Holdings ... - StreetInsider.com (NASDAQ:BIOS) www.streetinsider.com - September 12 at 8:38 AM
	BioScrip Completes Acquisition of Home Solutions Nasdaq:BIOS - GlobeNewswire (press release) (NASDAQ:BIOS) globenewswire.com - September 10 at 8:34 AM
	BioScrip Completes Acquisition of Home Solutions (NASDAQ:BIOS) www.publicnow.com - September 10 at 8:34 AM
	Making News: Targeting shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 9 at 3:45 PM
	Earnings Analysis & Update for BioScrip, Inc. (NASDAQ:BIOS)? - Frisco Fastball (NASDAQ:BIOS) friscofastball.com - September 9 at 3:45 PM
	A Price Target Of $3.916 Is Set By Research Analysts For BioScrip, Inc. (NASDAQ:BIOS) - RealistInvestor.com (NASDAQ:BIOS) www.realistinvestor.com - September 9 at 8:40 AM
	Focusing the Spotlight on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 8 at 3:45 PM
	Placing BioScrip, Inc. (NASDAQ:BIOS) Shares Under the ... - Post News (NASDAQ:BIOS) www.kentuckypostnews.com - September 8 at 8:16 AM
	Narrowing the Lens on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 7 at 3:51 PM
	BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic (NASDAQ:BIOS) biz.yahoo.com - September 7 at 12:34 PM
	New Denver medical company wants to speed up its big purchase (NASDAQ:BIOS) www.bizjournals.com - September 6 at 8:40 PM
	OTC Investors Supremely Interested in Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 6 at 3:34 PM
	HC Stocks Outlines- BioScrip Inc (BIOS), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release) (NASDAQ:BIOS) sharemarketupdates.com - September 6 at 3:34 PM
	BioScrip's Deal with Home Solutions Revised, To Close Soon (NASDAQ:BIOS) finance.yahoo.com - September 6 at 8:39 AM
	Price Target For BioScrip, Inc. (NASDAQ:BIOS) Set At $3.916 By ... - RealistInvestor.com (NASDAQ:BIOS) www.realistinvestor.com - September 4 at 3:42 PM
	BioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing - GlobeNewswire (press release) (NASDAQ:BIOS) globenewswire.com - September 3 at 8:30 AM
	BioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing (NASDAQ:BIOS) finance.yahoo.com - September 3 at 8:30 AM
	A Second Look at Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 2 at 3:41 PM
	Stock in Review: Taking a Closer Look at BioScrip, Inc. (NASDAQ:BIOS) Shares - Post News (NASDAQ:BIOS) www.kentuckypostnews.com - September 1 at 12:17 PM
	Under the Magnifying Glass: A Closer Look at BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - September 1 at 12:17 PM
	ETF’s with exposure to BioScrip, Inc. : August 31, 2016 (NASDAQ:BIOS) www.capitalcube.com - August 31 at 3:48 PM
	Zeroing Our Focus on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS) www.duncanindependent.com - August 30 at 3:48 PM
	BioScrip, Inc. (NASDAQ:BIOS) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NASDAQ:BIOS) voiceregistrar.com - August 30 at 3:48 PM
	BioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : August 30, 2016 (NASDAQ:BIOS) www.capitalcube.com - August 30 at 8:14 AM

Social

BioScrip (NASDAQ:BIOS) Chart for Friday, September, 30, 2016